Home LiteratureArticle Details
PMID: 23939832 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

MiR-26b is down-regulated in carcinoma-associated fibroblasts from ER-positive breast cancers leading to enhanced cell migration and invasion.

The Journal of pathology ·Vol. 231 ·No. 3 ·2013-11-00 ·Pages 388-99

Verghese ET, Drury R, Green CA, Holliday DL, Lu X, Nash C, Speirs V, Thorne JL, Thygesen HH, Zougman A, Hull MA, Hanby AM, Hughes TA

Abstract

Carcinoma-associated fibroblasts (CAFs) influence the behaviour of cancer cells but the roles of microRNAs in this interaction are unknown. We report microRNAs that are differentially expressed between breast normal fibroblasts and CAFs of oestrogen receptor-positive cancers, and explore the influences of one of these, miR-26b, on breast cancer biology. We identified differentially expressed microRNAs by expression profiling of clinical samples and a tissue culture model: miR-26b was the most highly deregulated microRNA. Using qPCR, miR-26b was confirmed as down-regulated in fibroblasts from 15 of 18 further breast cancers. Next, we examined whether manipulation of miR-26b expression changed breast fibroblast behaviour. Reduced miR-26b expression caused fibroblast migration and invasion to increase by up to three-fold in scratch-closure and trans-well assays. Furthermore, in co-culture with MCF7 breast cancer epithelial cells, fibroblasts with reduced miR-26b expression enhanced both MCF7 migration in trans-well assays and MCF7 invasion from three-dimensional spheroids by up to five-fold. Mass spectrometry was used to identify expression changes associated with the reduction of miR-26b expression in fibroblasts. Pathway analyses of differentially expressed proteins revealed that glycolysis/TCA cycle and cytoskeletal regulation by Rho GTPases are downstream of miR-26b. In addition, three novel miR-26b targets were identified (TNKS1BP1, CPSF7, COL12A1) and the expression of each in cancer stroma was shown to be significantly associated with breast cancer recurrence. MiR-26b in breast CAFs is a potent regulator of cancer behaviour in oestrogen receptor-positive cancers, and we have identified key genes and molecular pathways that act downstream of miR-26b in CAFs.

Keywords
fibroblast microRNA microRNA-26b stroma tumour microenvironment
MeSH Terms
Breast Neoplasms/genetics,metabolism,pathology Cell Movement Coculture Techniques Down-Regulation Female Fibroblasts/metabolism,pathology Gene Expression Profiling/methods Gene Expression Regulation, Neoplastic Humans MCF-7 Cells MicroRNAs/metabolism Neoplasm Invasiveness Oligonucleotide Array Sequence Analysis Paracrine Communication Polymerase Chain Reaction Receptors, Estrogen/metabolism Signal Transduction Time Factors Transfection Tumor Microenvironment
Chemicals
MIRN26A microRNA, human MicroRNAs Receptors, Estrogen
Authors & Affiliations
13 authors, click to expand affiliations / ORCID
Verghese Eldo T
Leeds Institute of Molecular Medicine, University of Leeds, Leeds, UK; Department of Histopathology, St James's University Hospital, Leeds, UK.
Drury Ruth
Green Caroline A
Holliday Deborah L
Lu Xiaomei
Nash Claire
Speirs Valerie
Thorne James L
Thygesen Helene H
Zougman Alexandre
Hull Mark A
Hanby Andrew M
Hughes Thomas A
References (51)
51 references, click to expand
  1. The telomeric poly(ADP-ribose) polymerase, tankyrase 1, contains multiple binding sites for telomeric repeat binding factor 1 (TRF1) and a novel acceptor, 182-kDa tankyrase-binding protein (TAB182).
    J Biol Chem. 2002 Apr 19;277(16):14116-26 PMID: 11854288
  2. miR-21-mediated tumor growth.
    Oncogene. 2007 Apr 26;26(19):2799-803 PMID: 17072344
  3. The reverse Warburg effect: aerobic glycolysis in cancer associated fibroblasts and the tumor stroma.
    Cell Cycle. 2009 Dec;8(23):3984-4001 PMID: 19923890
  4. Epithelial-mesenchymal interactions in breast cancer: evidence for a role of nuclear localized β-catenin in carcinoma-associated fibroblasts.
    Histopathology. 2011 Oct;59(4):609-18 PMID: 22014042
  5. Linear models and empirical bayes methods for assessing differential expression in microarray experiments.
    Stat Appl Genet Mol Biol. 2004;3:Article3 PMID: 16646809
  6. The impact of microRNAs on protein output.
    Nature. 2008 Sep 4;455(7209):64-71 PMID: 18668037
  7. Role of microRNA-26b in glioma development and its mediated regulation on EphA2.
    PLoS One. 2011 Jan 14;6(1):e16264 PMID: 21264258
  8. Two type XII-like collagens localize to the surface of banded collagen fibrils.
    J Cell Biol. 1991 May;113(4):971-8 PMID: 2026656
  9. Cancer stroma proteome expression profile of superficial bladder transitional cell carcinoma and biomarker discovery.
    J Cancer Res Clin Oncol. 2011 Aug;137(8):1273-82 PMID: 21706132
  10. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer.
    Nature. 2007 Oct 11;449(7163):682-8 PMID: 17898713
  11. Cross-talk between pRb/E2F and Wnt/beta-catenin pathways: E2F1 induces axin2 leading to repression of Wnt signalling and to increased cell death.
    Exp Cell Res. 2005 Feb 1;303(1):32-46 PMID: 15572025
  12. MicroRNA expression, survival, and response to interferon in liver cancer.
    N Engl J Med. 2009 Oct 8;361(15):1437-47 PMID: 19812400
  13. Small is beautiful: microRNAs and breast cancer-where are we now?
    J Pathol. 2008 Jul;215(3):214-21 PMID: 18446835
  14. Most mammalian mRNAs are conserved targets of microRNAs.
    Genome Res. 2009 Jan;19(1):92-105 PMID: 18955434
  15. Breast-cancer stromal cells with TP53 mutations and nodal metastases.
    N Engl J Med. 2007 Dec 20;357(25):2543-51 PMID: 18094375
  16. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion.
    Cell. 2005 May 6;121(3):335-48 PMID: 15882617
  17. Human embryonic stem cells and metastatic colorectal cancer cells shared the common endogenous human microRNA-26b.
    J Cell Mol Med. 2011 Sep;15(9):1941-54 PMID: 20831567
  18. Twist1 is up-regulated in gastric cancer-associated fibroblasts with poor clinical outcomes.
    Am J Pathol. 2011 Oct;179(4):1827-38 PMID: 21854747
  19. Biomechanical remodeling of the microenvironment by stromal caveolin-1 favors tumor invasion and metastasis.
    Cell. 2011 Jul 8;146(1):148-63 PMID: 21729786
  20. Distinct epigenetic changes in the stromal cells of breast cancers.
    Nat Genet. 2005 Aug;37(8):899-905 PMID: 16007089
  21. Autocrine TGF-beta and stromal cell-derived factor-1 (SDF-1) signaling drives the evolution of tumor-promoting mammary stromal myofibroblasts.
    Proc Natl Acad Sci U S A. 2010 Nov 16;107(46):20009-14 PMID: 21041659
  22. Lithium inhibits invasion of glioma cells; possible involvement of glycogen synthase kinase-3.
    Neuro Oncol. 2008 Oct;10(5):690-9 PMID: 18715951
  23. Fibroblast-led collective invasion of carcinoma cells with differing roles for RhoGTPases in leading and following cells.
    Nat Cell Biol. 2007 Dec;9(12):1392-400 PMID: 18037882
  24. Transcription factor networks in invasion-promoting breast carcinoma-associated fibroblasts.
    Cancer Microenviron. 2013 Apr;6(1):91-107 PMID: 23090154
  25. Mammalian microRNAs predominantly act to decrease target mRNA levels.
    Nature. 2010 Aug 12;466(7308):835-40 PMID: 20703300
  26. Dichloroacetate induces apoptosis and cell-cycle arrest in colorectal cancer cells.
    Br J Cancer. 2010 Jun 8;102(12):1746-52 PMID: 20485289
  27. Stromal gene expression predicts clinical outcome in breast cancer.
    Nat Med. 2008 May;14(5):518-27 PMID: 18438415
  28. Proteomic signatures of the desmoplastic invasion front reveal collagen type XII as a marker of myofibroblastic differentiation during colorectal cancer metastasis.
    Oncotarget. 2012 Mar;3(3):267-85 PMID: 22408128
  29. Stromal fibroblasts in cancer initiation and progression.
    Nature. 2004 Nov 18;432(7015):332-7 PMID: 15549095
  30. Pten in stromal fibroblasts suppresses mammary epithelial tumours.
    Nature. 2009 Oct 22;461(7267):1084-91 PMID: 19847259
  31. Origin and function of tumor stroma fibroblasts.
    Semin Cell Dev Biol. 2010 Feb;21(1):40-6 PMID: 19944178
  32. MiRNA expression analysis of cancer-associated fibroblasts and normal fibroblasts in breast cancer.
    Int J Biochem Cell Biol. 2012 Nov;44(11):2051-9 PMID: 22964023
  33. Glycolytic cancer associated fibroblasts promote breast cancer tumor growth, without a measurable increase in angiogenesis: evidence for stromal-epithelial metabolic coupling.
    Cell Cycle. 2010 Jun 15;9(12):2412-22 PMID: 20562527
  34. High expression of miR-21 in tumor stroma correlates with increased cancer cell proliferation in human breast cancer.
    APMIS. 2011 Oct;119(10):663-73 PMID: 21917003
  35. Global microRNA expression profiling of high-risk ER+ breast cancers from patients receiving adjuvant tamoxifen mono-therapy: a DBCG study.
    PLoS One. 2012;7(5):e36170 PMID: 22623953
  36. MicroRNA profiling and head and neck cancer.
    Comp Funct Genomics. 2009;:837514 PMID: 19753298
  37. Evidence that cleavage factor Im is a heterotetrameric protein complex controlling alternative polyadenylation.
    Genes Cells. 2010 Sep 1;15(9):1003-13 PMID: 20695905
  38. Clinical and functional significance of loss of caveolin-1 expression in breast cancer-associated fibroblasts.
    J Pathol. 2012 Aug;227(4):490-8 PMID: 22488553
  39. Dynamics of the Rho-family small GTPases in actin regulation and motility.
    Cell Adh Migr. 2011 Mar-Apr;5(2):170-80 PMID: 21178402
  40. Cellular changes involved in conversion of normal to malignant breast: importance of the stromal reaction.
    Physiol Rev. 1996 Jan;76(1):69-125 PMID: 8592733
  41. Spheroid confrontation assay: a simple method to monitor the three-dimensional migration of different cell types in vitro.
    Ann Anat. 2011 May;193(3):181-4 PMID: 21339059
  42. The role of the microenvironment in mammary gland development and cancer.
    Cold Spring Harb Perspect Biol. 2010 Nov;2(11):a003244 PMID: 20591988
  43. The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis.
    Nat Cell Biol. 2008 Feb;10(2):202-10 PMID: 18193036
  44. Universal sample preparation method for proteome analysis.
    Nat Methods. 2009 May;6(5):359-62 PMID: 19377485
  45. MicroRNA-26b is underexpressed in human breast cancer and induces cell apoptosis by targeting SLC7A11.
    FEBS Lett. 2011 May 6;585(9):1363-7 PMID: 21510944
  46. A practical guide to the MaxQuant computational platform for SILAC-based quantitative proteomics.
    Nat Protoc. 2009;4(5):698-705 PMID: 19373234
  47. Reconstruction of functionally normal and malignant human breast tissues in mice.
    Proc Natl Acad Sci U S A. 2004 Apr 6;101(14):4966-71 PMID: 15051869
  48. Identification of fibroblast heterogeneity in the tumor microenvironment.
    Cancer Biol Ther. 2006 Dec;5(12):1640-6 PMID: 17106243
  49. RNA sequencing of pancreatic circulating tumour cells implicates WNT signalling in metastasis.
    Nature. 2012 Jul 26;487(7408):510-3 PMID: 22763454
  50. Tumor cell migration in three dimensions.
    Methods Enzymol. 2006;406:625-43 PMID: 16472693
  51. No evidence of clonal somatic genetic alterations in cancer-associated fibroblasts from human breast and ovarian carcinomas.
    Nat Genet. 2008 May;40(5):650-5 PMID: 18408720
Article Info
Journal
The Journal of pathology
Abbr.
J Pathol
ISSN
1096-9896
Published
2013-11-00
Pages
388-99
Language
English
Region
England
NLM ID
0204634
PMCID
PMC4030585
Subset
IM
Grants
Medical Research Council · G0902032 · United Kingdom
Cancer Research UK · C37059/A11941 · United Kingdom
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]